Both live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV)
induce protective immunity against influenza. There is evidence that LAIV induces superior …

In an attempt to assess the cross-protective potential of the influenza virus neuraminidase
(NA) as a vaccine antigen, different subtypes of recombinant NA were expressed in a …

Influenza infection remains a global threat to human health. Influenza viruses are normally
controlled by antibodies specific for the surface glycoproteins hemagglutinin (HA) and …

Despite use of influenza vaccines for more than 65 y, influenza and its complications are a
major cause of morbidity and mortality worldwide. Most deaths during influenza virus …

Background. Inactivated influenza vaccine (IIV) is recommended during pregnancy to
prevent influenza infection and its complications in pregnant women and their infants …

Background. Previous studies have established that antibody titer measured by the
hemagglutination-inhibiting (HAI) assay is correlated with protection against influenza virus …

Influenza virus hemagglutinin (HA) surface glycoprotein is currently the primary target of
licensed influenza vaccines. Recently, broadly reactive antibodies that target the stalk region …

Neutralizing antibodies against hemagglutinin (HA) of influenza viruses are considered the
main immune mechanism that correlates with protection for influenza infections …

The novel influenza A (H1N1) pdm09 virus caused an influenza pandemic in 2009. IgM, IgG,
and IgA antibody responses to A (H1N1) pdm09 hemagglutinin (HA) following A (H1N1) …

Seasonal influenza viruses are a major cause of human disease worldwide. Most
neutralizing antibodies (Abs) elicited by influenza viruses target the head domain of the …